Birch Hill Investment Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Birch Hill Investment Advisors LLC

$2.06 Billion
Q3 2024

A detailed history of Birch Hill Investment Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Birch Hill Investment Advisors LLC holds 168,157 shares of VRTX stock, worth $75.7 Million. This represents 3.8% of its overall portfolio holdings.

Number of Shares

168,157

Previous 171,499 1.95%

Holding current value

$75.7 Million

Previous $80.4 Million 2.71%

% of portfolio

3.8%

Previous 3.97%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$460.0 - $505.78 $1.54 Million - $1.69 Million	-3,342 Reduced 1.95%	168,157 $78.2 Million
Q2 2024 Jul 30, 2024	SELL	$392.81 - $485.53 $90,739 - $112,157	-231 Reduced 0.13%	171,499 $80.4 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $6.36 Million - $6.96 Million	-15,604 Reduced 8.33%	171,730 $71.8 Million
Q4 2023 Jan 29, 2024	BUY	$343.0 - $410.68 $567,322 - $679,264	1,654 Added 0.89%	187,334 $76.2 Million
Q3 2023 Oct 19, 2023	SELL	$338.18 - $362.46 $309,434 - $331,650	-915 Reduced 0.49%	185,680 $64.6 Million
Q2 2023 Jul 20, 2023	SELL	$314.42 - $351.91 $1.52 Million - $1.7 Million	-4,835 Reduced 2.53%	186,595 $65.7 Million
Q1 2023 Apr 14, 2023	SELL	$283.23 - $323.1 $3.65 Million - $4.17 Million	-12,893 Reduced 6.31%	191,430 $60.3 Million
Q4 2022 Jan 31, 2023	SELL	$285.76 - $321.48 $1.76 Million - $1.98 Million	-6,173 Reduced 2.93%	204,323 $59 Million
Q3 2022 Oct 19, 2022	SELL	$273.83 - $305.53 $1.85 Million - $2.06 Million	-6,750 Reduced 3.11%	210,496 $60.9 Million
Q2 2022 Jul 13, 2022	SELL	$234.96 - $292.55 $3.96 Million - $4.93 Million	-16,856 Reduced 7.2%	217,246 $61.2 Million
Q1 2022 Apr 08, 2022	SELL	$221.42 - $260.97 $2.91 Million - $3.43 Million	-13,137 Reduced 5.31%	234,102 $61.1 Million
Q4 2021 Feb 02, 2022	BUY	$177.01 - $223.45 $8.87 Million - $11.2 Million	50,095 Added 25.41%	247,239 $54.3 Million
Q3 2021 Oct 25, 2021	BUY	$181.39 - $202.99 $284,782 - $318,694	1,570 Added 0.8%	197,144 $35.8 Million
Q2 2021 Jul 22, 2021	BUY	$187.49 - $221.1 $7.39 Million - $8.71 Million	39,389 Added 25.22%	195,574 $39.4 Million
Q1 2021 Apr 26, 2021	BUY	$207.02 - $241.31 $32.3 Million - $37.7 Million	156,185 New	156,185 $33.6 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Birch Hill Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Birch Hill Investment Advisors LLC with notifications on news.

Account

Birch Hill Investment Advisors LLC Vertex Pharmaceuticals Inc Transaction History